PUBLISHER: TechNavio | PRODUCT CODE: 2056250
PUBLISHER: TechNavio | PRODUCT CODE: 2056250
Global Digital Biology Market 2026-2030
The global digital biology market is forecasted to grow by USD 29883.8 mn during 2025-2030, accelerating at a CAGR of 20.1% during the forecast period. The report on the global digital biology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of ai and ml in genomic sequencing , exponential growth in bioinformatics and cloud computing infrastructure, increasing investments and funding in synthetic biology initiatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 16.8% |
| CAGR | 20.1% |
| Incremental Value | $29883.8 mn |
Technavio's global digital biology market is segmented as below:
By Application
- Drug discovery
- Synthetic biology
- Precision medicine
- Clinical diagnostics
- Agricultural biotechnology
By End-User
- Pharmaceutical companies
- Biotechnology companies
- Research institutes
- Healthcare providers
- Agricultural companies
By Component
- Solutions
- Services
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of digital twin technology in pharmaceutical drug discovery as one of the prime reasons driving the global digital biology market growth during the next few years. Also, rise of decentralized and blockchain enabled platforms for genomic data security and integration of quantum computing for simulating complex biological molecular systems will lead to sizable demand in the market.
The report on the global digital biology market covers the following areas:
- Global digital biology market sizing
- Global digital biology market forecast
- Global digital biology market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global digital biology market vendors that include 10X Genomics Inc., AbCellera Biologics Inc., Asimov Inc, Benchling Inc., BenevolentAI, Cradle, DNAnexus Inc., Generate Biomedicines, Ginkgo Bioworks Holdings Inc., Illumina Inc., Insilico Medicine, Isomorphic Labs, Microsoft Corp., NVIDIA Corp., Recursion Pharmaceuticals Inc., Relay Therapeutics Inc., Schrodinger Inc., Tempus AI Inc., Twist Bioscience Corp., Valo Health. Also, the global digital biology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Component
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Digital Biology Market 2020 - 2024
- Historic Market Size - Data Table on Global Digital Biology Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Component segment analysis 2020 - 2024
- Historic Market Size - Component Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Digital Biology Market
- 6.2 Impact of geopolitical Conflicts on Global Digital Biology Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Drug discovery - Market size and forecast 2025-2030
- 8.4 Synthetic biology - Market size and forecast 2025-2030
- 8.5 Precision medicine - Market size and forecast 2025-2030
- 8.6 Clinical diagnostics - Market size and forecast 2025-2030
- 8.7 Agricultural biotechnology - Market size and forecast 2025-2030
- 8.8 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharmaceutical companies - Market size and forecast 2025-2030
- 9.4 Biotechnology companies - Market size and forecast 2025-2030
- 9.5 Research institutes - Market size and forecast 2025-2030
- 9.6 Healthcare providers - Market size and forecast 2025-2030
- 9.7 Agricultural companies - Market size and forecast 2025-2030
- 9.8 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Component
- 10.1 Market segments
- 10.2 Comparison by Component
- 10.3 Solutions - Market size and forecast 2025-2030
- 10.4 Services - Market size and forecast 2025-2030
- 10.5 Market opportunity by Component
- Market opportunity by Component ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.5.7 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Integration of AI and ML in genomic sequencing
- Exponential growth in bioinformatics and cloud computing infrastructure
- Increasing investments and funding in synthetic biology initiatives
- 13.2 Market challenges
- Data privacy concerns and cybersecurity vulnerabilities in biological databases
- Interoperability limitations and lack of standardized data formats
- Severe shortage of multidisciplinary talent and skilled professionals
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of digital twin technology in pharmaceutical drug discovery
- Rise of decentralized and blockchain enabled platforms for genomic data security
- Integration of quantum computing for simulating complex biological molecular systems
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 10X Genomics Inc.
- 10X Genomics Inc. - Overview
- 10X Genomics Inc. - Product / Service
- 10X Genomics Inc. - Key offerings
- SWOT
- 15.5 Benchling Inc.
- Benchling Inc. - Overview
- Benchling Inc. - Product / Service
- Benchling Inc. - Key offerings
- SWOT
- 15.6 BenevolentAI
- BenevolentAI - Overview
- BenevolentAI - Product / Service
- BenevolentAI - Key offerings
- SWOT
- 15.7 DNAnexus Inc.
- DNAnexus Inc. - Overview
- DNAnexus Inc. - Product / Service
- DNAnexus Inc. - Key offerings
- SWOT
- 15.8 Generate Biomedicines
- Generate Biomedicines - Overview
- Generate Biomedicines - Product / Service
- Generate Biomedicines - Key offerings
- SWOT
- 15.9 Ginkgo Bioworks Holdings Inc.
- Ginkgo Bioworks Holdings Inc. - Overview
- Ginkgo Bioworks Holdings Inc. - Business segments
- Ginkgo Bioworks Holdings Inc. - Key offerings
- Ginkgo Bioworks Holdings Inc. - Segment focus
- SWOT
- 15.10 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.11 Insilico Medicine
- Insilico Medicine - Overview
- Insilico Medicine - Product / Service
- Insilico Medicine - Key offerings
- SWOT
- 15.12 Isomorphic Labs
- Isomorphic Labs - Overview
- Isomorphic Labs - Product / Service
- Isomorphic Labs - Key offerings
- SWOT
- 15.13 Microsoft Corp.
- Microsoft Corp. - Overview
- Microsoft Corp. - Business segments
- Microsoft Corp. - Key news
- Microsoft Corp. - Key offerings
- Microsoft Corp. - Segment focus
- SWOT
- 15.14 NVIDIA Corp.
- NVIDIA Corp. - Overview
- NVIDIA Corp. - Business segments
- NVIDIA Corp. - Key news
- NVIDIA Corp. - Key offerings
- NVIDIA Corp. - Segment focus
- SWOT
- 15.15 Recursion Pharmaceuticals Inc.
- Recursion Pharmaceuticals Inc. - Overview
- Recursion Pharmaceuticals Inc. - Product / Service
- Recursion Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.16 Schrodinger Inc.
- Schrodinger Inc. - Overview
- Schrodinger Inc. - Business segments
- Schrodinger Inc. - Key news
- Schrodinger Inc. - Key offerings
- Schrodinger Inc. - Segment focus
- SWOT
- 15.17 Tempus AI Inc.
- Tempus AI Inc. - Overview
- Tempus AI Inc. - Product / Service
- Tempus AI Inc. - Key offerings
- SWOT
- 15.18 Twist Bioscience Corp.
- Twist Bioscience Corp. - Overview
- Twist Bioscience Corp. - Product / Service
- Twist Bioscience Corp. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
